Moderna Inc

NASDAQ:MRNA   12:15:26 PM EDT
343.73
-5.59 (-1.60%)
Products, Expansion, Regulatory

Moderna Says Recipharm Site In France Manufacturing COVID-19 Vaccine Moderna Following Approval By EMA

Published: 07/01/2021 13:41 GMT
Moderna Inc (MRNA) - Moderna Announces Recipharm Site in France Manufacturing Covid-19 Vaccine Moderna Following Approval by European Medicines Agency.
Moderna Inc - Drug Product Manufacture at Recipharm Monts Has Begun.